SCHEMBL25462010

SCHEMBL25462010

c1ccc2c(c1)sc1cc(-c3nccc4ccncc34)ncc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.37
KDM4E B2RXH2 5/20 0.36
HTT P42858 2/20 0.36
POLB P06746 1/20 0.36
RAD52 P43351 1/20 0.36
RAB9A P51151 4/20 0.36
MAPT P10636 3/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAPK10 P53779 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.34
ROCK1 Q13464 1/20 0.33
TNF P01375 1/20 0.33
GABRA1 P14867 2/20 0.33
MIF P14174 1/20 0.33
NPC1 O15118 3/20 0.31
GRM4 Q14833 1/20 0.31
CYP2A6 P11509 1/20 0.31
F12 P00748 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25461900 0.92 KDM4E (0.36) KDM4EHTTPOLBRAD52RAB9A
SCHEMBL25462008 0.91 MAPT (0.38) GPR3KDM4EHTTPOLBRAD52
SCHEMBL25461707 0.91 GPR3 (0.40) GPR3KDM4ERAB9AMAPTALDH1A1
SCHEMBL25462007 0.90 GABRA1 (0.38) GPR3KDM4EHTTPOLBRAD52
SCHEMBL25461854 0.88 KDM4E (0.35) KDM4EHTTPOLBRAD52RAB9A
SCHEMBL25461845 0.83 KDM4E (0.36) KDM4EHTTPOLBRAD52RAB9A
SCHEMBL25462015 0.81 GRM4 (0.44) GPR3KDM4EHTTPOLBRAD52
SCHEMBL25462014 0.81 GRM4 (0.39) GPR3KDM4EHTTPOLBRAD52
SCHEMBL25461992 0.81 GABRA1 (0.38) GPR3KDM4EHTTPOLBRAD52
SCHEMBL25462011 0.81 KDM4E (0.38) GPR3KDM4EHTTPOLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, EHD1 GPR3 4426/4885KDM4E 2555/4885HTT 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.